RECRUITINGINTERVENTIONAL

The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality of Life of Patients With Celiac Disease

About This Trial

This randomized controlled trial aims to evaluate the effect of a navigator nurse-supported mobile application, developed based on the Information-Motivation-Behavioral Skills (IMB) model, on the quality of life of adult patients newly diagnosed with celiac disease. Participants will be randomized into intervention and control groups. The intervention group will use the mobile application with navigator nurse support for six months, while the control group will receive routine clinical education. Outcomes will be assessed through validated questionnaires and clinical data.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥18 years - Newly diagnosed with celiac disease - Owning a smartphone and able to use the application - Able to speak and understand Turkish - Voluntary participation (willing to sign a consent form) Who Should NOT Join This Trial: - Severe gluten hypersensitivity - Failure to meet inclusion criteria - Withdrawal of consent during the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Age ≥18 years * Newly diagnosed with celiac disease * Owning a smartphone and able to use the application * Able to speak and understand Turkish * Voluntary participation (informed consent) Exclusion Criteria: * Severe gluten hypersensitivity * Failure to meet inclusion criteria * Withdrawal of consent during the study

Treatments Being Tested

BEHAVIORAL

IMB navigator app

Mobile application developed based on the IMB model, supported by a navigator nurse. Includes educational content, reminders and behavioral support. Patients will be followed for 6 months.

Locations (1)

Ankara Etlik City Hospital

Ankara, Ankara, Turkey (Türkiye)